Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

OBJECTIVE: Lung cancer is an important health problem due to its high incidence and mortality. The treatment of metastatic disease improved after the molecular pathways of cancer came to be known. However, targeted therapy is unavailable to many patients treated within the Brazilian Sistema Único de...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiar, Pedro, Roitberg, Felipe, Lopes, Gilberto, del Giglio, Auro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567624/
https://www.ncbi.nlm.nih.gov/pubmed/32490907
http://dx.doi.org/10.36416/1806-3756/e20180255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567624/
https://www.ncbi.nlm.nih.gov/pubmed/32490907
http://dx.doi.org/10.36416/1806-3756/e20180255

Ejemplares similares